Ambryon Biosciences

AAV-ShH10 Serotype

Simian-human hybrid AAV combining rhesus and human capsid elements for broad tissue tropism with lower pre-existing immunity in human populations.

TropismLiver, CNS, muscle (broad tropism)

Characteristics

Hybrid capsid from simian and human AAV sources. Lower pre-existing neutralizing antibodies versus AAV2. Broad tissue tropism across liver, CNS, and muscle. Enhanced transduction efficiency. Favorable immune profile.

Applications

Hemophilia gene therapy. CNS disease applications. Multi-tissue gene therapy requiring broad tropism. Clinical applications in antibody-positive patients.

Sequence1 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Choudhury et al. (2016). Viral vectors for therapy of neurologic diseases. Mol Ther — Choudhury 2016 ShH10

Identifiers & revision